Gilder Gagnon Howe & CO LLC Cytokinetics Inc Transaction History

Gilder Gagnon Howe & CO LLC

$8.39 Billion
Q2 2025

A detailed history of Gilder Gagnon Howe & CO LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 191,115 shares of CYTK stock, worth $11.3 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

191,115

Previous 14,862 1185.93%

Holding current value

$11.3 Million

Previous $597,000 957.62%

% of portfolio

0.08%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$29.84 - $42.92 $5.26 Million - $7.56 Million	176,253 Added 1185.93%	191,115 $6.31 Million
Q1 2025 May 15, 2025	BUY	$40.19 - $51.12 $119,364 - $151,826	2,970 Added 24.97%	14,862 $597,000
Q4 2024 Feb 14, 2025	SELL	$46.36 - $58.62 $77,096 - $97,485	-1,663 Reduced 12.27%	11,892 $559,000
Q3 2024 Nov 14, 2024	SELL	$51.22 - $60.16 $14,085 - $16,544	-275 Reduced 1.99%	13,555 $715,000
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $10,577 - $16,586	-221 Reduced 1.57%	13,830 $749,000
Q1 2024 May 15, 2024	SELL	$63.75 - $108.06 $783,742 - $1.33 Million	-12,294 Reduced 46.67%	14,051 $985,000
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $5,053 - $15,696	-188 Reduced 0.71%	26,345 $2.2 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $2,032 - $2,526	69 Added 0.26%	26,533 $781,000
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $12,167 - $15,199	-373 Reduced 1.39%	26,464 $863,000
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $16,112 - $22,077	-483 Reduced 1.77%	26,837 $944,000
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $53,118 - $75,898	1,485 Added 5.75%	27,320 $1.25 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $995,680 - $1.41 Million	25,835 New	25,835 $1.25 Million

Others Institutions Holding CYTK

# of Institutions

385

Shares Held

129M

Call Options Held

3.62M

Put Options Held

1.14M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.59B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Account

Gilder Gagnon Howe & CO LLC Cytokinetics Inc Transaction History